Thyrocare Tech. Peer Comparison

Snapshot Summary

Thyrocare Technologies Ltd. stands out among its peers with solid revenue growth and low debt levels while maintaining a competitive position in profitability metrics. However, it is relatively overvalued compared to some peers, making it a potential candidate for cautious investment.

• Thyrocare shows strong revenue growth at 20.19% YoY and low debt equity ratio of 0.0413.
• Max Healthcare has the highest PE ratio of 163.58, indicating potential overvaluation.
• Aster DM Healthcare is the best value pick with a PE of 5.05 and decent profitability metrics.

• Narayana Hrudayalaya Ltd.: Highest ROE at 24.27% and solid EPS growth.
• Thyrocare Technologies Ltd.: Strong revenue growth at 20.19% YoY and low debt levels.
• Global Health Ltd.: Good balance of growth and profitability with a solid ROE of 15.31%.

Stock	CMP	Market Cap	P/E	ROE (%)	ROCE (%)	Debt/Equity
THYROCARE	₹1,381.30	₹7,332.84Cr	57.41	17.04%	27.25%	-
APOLLOHOSP	₹7,824.50	₹1,12,510.06Cr	71.50	20.51%	21.19%	0.67
MAXHEALTH	₹1,145.90	₹1,11,466.91Cr	97.13	13.47%	16.26%	0.14
FORTIS	₹1,030.70	₹77,269.97Cr	88.97	9.77%	12.14%	0.25
NH	₹1,785.00	₹36,492.71Cr	46.46	24.27%	21.62%	0.61
ASTERDM	₹678.45	₹35,159.69Cr	110.51	9.32%	11.46%	0.19
MEDANTA	₹1,274.60	₹34,290.93Cr	64.20	15.31%	20.50%	0.10

Explore

Watchlists

Command Palette

Thyrocare Tech. Peer Comparison

Snapshot Summary